ANDA 76482, held by Roxane. Metolazone.
As of Nov 16, 2026, ANDA 76482 (Metolazone), held by Roxane, was first approved by FDA on Apr 29, 2004, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 29, 2004 | Original application | Approved | None posted |
| Metolazone10MG · tablet; oral | Metolazone | Rx |
| Metolazone10MG · tablet;oral | Metolazone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters